Is Sonnet Biotherapeutics Holdings Inc halal to invest in?

As of July 2026, Sonnet Biotherapeutics Holdings Inc SONN is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.

Is Sonnet Biotherapeutics Holdings Inc a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Sonnet Biotherapeutics Holdings Inc using these criteria to determine its compliance status.

Can Muslims buy shares of Sonnet Biotherapeutics Holdings Inc?

Muslim investors may consider investing in Sonnet Biotherapeutics Holdings Inc if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Sonnet Biotherapeutics Holdings Inc classified as HALAL?

Musaffa determines the Shariah status of Sonnet Biotherapeutics Holdings Inc by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Sonnet Biotherapeutics Holdings Inc updated?

The Shariah compliance status of Sonnet Biotherapeutics Holdings Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Sonnet Biotherapeutics Holdings Inc become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Sonnet Biotherapeutics Holdings Inc?

You can check the latest Shariah compliance status of Sonnet Biotherapeutics Holdings Inc on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Sonnet Biotherapeutics Holdings Inc SONN

Last Updated: Dec 02, 12:00 AM·BE

SONN Shariah Compliance

Screening Methodology: AAOIFI

As of July 2026, Sonnet Biotherapeutics Holdings Inc is classified as halal.

HALAL

Report Source: 2025 3rd Quarter Report

Sonnet Biotherapeutics Holdings Inc. Stock Analysis SONN

Germany Health Care Nano Cap Report: Q3, 2025

Sonnet BioTherapeutics Holdings, Inc. is a clinical stage biotechnology company, which engages in the innovation of biologic medicines. The company is headquartered in Princeton, New Jersey and currently employs 13 full-time employees. The company went IPO on 2005-07-27. The Fully Human Albumin Binding (FHAB), a technology which utilizes a fully human single chain antibody fragment that binds to and hitch-hikes on human serum albumin for transport to target tissues. Its FHAB is designed to specifically target tumor and lymphatic tissue. The firm's lead program, SON-1010, or IL-12-FHAB, is in development for the treatment of solid tumors and ovarian cancer. SON-1010 is being evaluated in an ongoing Phase 1/2a study, in combination with atezolizumab (Tecentriq) for the treatment of platinum-resistant ovarian cancer (PROC). The firm is also evaluating its second program, SON-1210, an IL12-FHAB-IL15 for solid tumor. Its SON-080 program is a low dose of rhIL-6 in development for Chemotherapy-Induced Peripheral Neuropathy (CIPN) and Diabetic Peripheral Neuropathy (DPN).

Key Statistics of Sonnet Biotherapeutics Holdings Inc (SONN)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$1.26$3.23

Today's Open

$3.16

Volume

10.46M

P/E Ratio (TTM)

52 Week Range

$1.26$7.90

Market Cap

3.74M

Avg. Volume

1.18M

Dividend Yield

Financial Metrics & Statements of Sonnet Biotherapeutics Holdings Inc (SONN)

Super Investors Invested in Sonnet Biotherapeutics Holdings Inc (SONN)

FAQ's for Sonnet Biotherapeutics Holdings Inc (SONN)

As of July 2026, Sonnet Biotherapeutics Holdings Inc SONN is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Sonnet Biotherapeutics Holdings Inc using these criteria to determine its compliance status.
Muslim investors may consider investing in Sonnet Biotherapeutics Holdings Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
Musaffa determines the Shariah status of Sonnet Biotherapeutics Holdings Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
The Shariah compliance status of Sonnet Biotherapeutics Holdings Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
You can check the latest Shariah compliance status of Sonnet Biotherapeutics Holdings Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.